These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 338271

  • 21. The use of stimulant medication with children.
    Phillips S.
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract] [Full Text] [Related]

  • 22. Pemoline and lithium in a patient with attention deficit disorder.
    Brown RP, Ingber PS, Tross S.
    J Clin Psychiatry; 1983 Apr; 44(4):146-8. PubMed ID: 6403515
    [No Abstract] [Full Text] [Related]

  • 23. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
    Barkley RA.
    J Clin Psychiatry; 2002 Apr; 63 Suppl 12():36-43. PubMed ID: 12562060
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
    Wender PH, Wood DR, Reimherr FW.
    Psychopharmacol Bull; 1985 Apr; 21(2):222-31. PubMed ID: 3923527
    [No Abstract] [Full Text] [Related]

  • 25. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
    Rao JK, Julius JR, Breen TJ, Blethen SL.
    Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
    [Abstract] [Full Text] [Related]

  • 26. Psychopharmacology of ADHD in adolescents.
    Greydanus DE, Sloane MA, Rappley MD.
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [Abstract] [Full Text] [Related]

  • 27. Drug treatment for hyperactive children. Therapeutic guidelines.
    Elia J.
    Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
    [Abstract] [Full Text] [Related]

  • 28. Blood levels and tolerance to stimulants in ADDH children.
    Swanson JM, Lerner M, Cantwell D.
    Clin Neuropharmacol; 1986 Nov; 9 Suppl 4():523-5. PubMed ID: 3567959
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effectiveness of attention-deficit/hyperactivity treatment and diagnosis methods tested.
    Rep Med Guidel Outcomes Res; 2000 Feb 17; 11(4):1-2, 5-7. PubMed ID: 11768409
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Pietrzak RH, Mollica CM, Maruff P, Snyder PJ.
    Neurosci Biobehav Rev; 2006 Feb 17; 30(8):1225-45. PubMed ID: 17161238
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pemoline: review of performance.
    Plotnikoff N.
    Tex Rep Biol Med; 1971 Feb 17; 29(4):467-79. PubMed ID: 4337779
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.